Page 2 - reflections_newsletter_June8_2022
P. 2
REFLECTIONS dae mia
Dyslipidaemia Global Newsletter #2
aim ead
Dyslipi
secondary causes of hypertriglyceridaemia, lifestyle interventions for management of hypertriglyceridaemia, the role of statin theDryaslpipiy
in patients with persistent hypertriglyceridaemia, and the role for triglyceride risk-based therapies for ASCVD risk reduction.
The algorithms created by the authors include a detailed clinical workflow for each patient scenario based on ASCVD, age,
comorbidities, fasting TG, and nonfasting TG levels.
TABLE OF CONTENTS Learn more at: www.serviercardiomedicalhub.com
